Login
Oncology Education
 
Register new Account
Recover Password
NAVIGATION
  • Home
  • About Us
  • Tumour Sites
    • Breast
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • GI
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • Lung
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • GU
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • Head & Neck
      • Videos
      • Podcasts
    • Hematology
      • Videos
      • Slides
      • Podcasts
    • Melanoma
      • Videos
      • Slides
      • Podcasts
    • Gynecology
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • Global Cancer Control
      • Videos
      • Podcasts
    • Other Topics
      • Videos
      • Slides
      • Podcasts
  • Resources
    • Events
    • OE Event Videos
    • Cancer Congress Coverage
    • Speaker Spotlight
    • Podcasts
    • Trainee Resources
    • E-Learning Portal
    • Best of Oncology Weekly
    • Job Postings
    • Cancer and Aging
  • COVID-19 Resources
  • Login/Account
    • Register new Account
    • Recover Password
    • Login
    • Contact Us
  • Search
  • home
  • Tumour Sites
  • Lung
  • Videos

Recent Videos

Lung Cancer

Featuring:
Dr. Ying Wang

Change on the Horizon: Updates in Small Cell Lung Cancer

Featuring:
Dr. Peter Ellis
Chair:
Dr. Stephanie Snow

Change on the Horizon: Updates in Small Cell Lung Cancer

Featuring:
Dr. Peter Ellis
Chair:
Dr. Stephanie Snow

Change on the Horizon: Updates in Small Cell Lung Cancer

Featuring:
Dr. Peter Ellis
Chair:
Dr. Stephanie Snow

Small Cell Lung Cancer: Raising the Bar [Quebec Perspectives]

Featuring:
Dr. Jason Agulnik
Chair:
Dr. Normand Blais

Updates and Optimizing Treatment Outcomes in AML Management

Featuring:
Dr. Andre Schuh
Dr. Brian Leber
Chair:
Dr. Lynn Savoie

Lung Cancer

Featuring:
Dr. Jeff Rothenstein

The future of Immuno-Oncology in SCLC in Canada & update on new therapies

Featuring:
Dr. David Dawe

Screening Update

Featuring:
Dr. Renelle Myers

SBRT Update - Radiation for limited stage small cell - is it time to standardize Canadian practice?

Featuring:
Dr. Alexander Louie

Current State of Biomarker Testing

Featuring:
Dr. Brandon Sheffield

Surgical Update: Impact of Covid-19 on Lung Cancer Surgery

Featuring:
Dr. Jonathan Spicer

Immunotherapy Debate: What is the Best Treatment for PDL1-negative Patients with Advanced NSCLC? Part-2

Featuring:
Dr. Stephanie Snow

Immunotherapy Debate: What is the Best Treatment for PDL1-negative Patients with Advanced NSCLC? Part-1

Featuring:
Dr. Rosalyn Juergens

Adjuvant Therapy in Resected NSCLC EGFRM+ PItfalls in ADAURA

Featuring:
Dr. Barbara Melosky

Adjuvant Therapy in Resected NSCLC EGFRM+ Why We Adore ADAURA

Featuring:
Dr. Normand Blais

Small Cell Lung Cancer: Raising the Bar

Featuring:
Dr. Quincy Chu
Chair:
Dr. Barbara Melosky

Lung Cancer

Featuring:
Dr. Quincy Chu

durvalumab in NSCLC and PRINCEPS trial

Neoadjuvant Trials
Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Peter Ellis

4-year survival of PACIFIC trial

Stage III NSCLC
Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Peter Ellis

Amivantamab & Lazertinib and Patritumab Deruxtecan

Metastatic NSCLC & EGFR Conjugates
Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Peter Ellis

ZENITH20 and TAK-788

Metastatic NSCLC
Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Peter Ellis

CROWN, ADAURA and Lung Art

Presidential Symposiums
Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Peter Ellis

First results from the FORCE trial

Featuring:
Dr. Farastuk Bozorgmehr

KEYNOTE-024

Featuring:
Dr. Julie Brahmer

Lung ART Trial

Featuring:
Dr. Cécile Le Pechoux

ACTIVE Trial

Featuring:
Dr. Li Zhang

EMPOWER-Lung 1 trial

Featuring:
Dr. Ahmet Sezer

A first analysis of the PIONeeR Study

Featuring:
Dr. Fabrice Barlesi

Defining the scope of eligibility for concurrent chemoradiation therapy for NSCLC

Featuring:
Dr. Parneet Cheema
Dr. Anthony Brade

ADAURA Trial: CNS disease recurrence

Featuring:
Dr. Masahiro Tsuboi

REACTION Study

Featuring:
Dr. Benjamin Besse

ESMO 2020 Virtual Data Watch - Lung Cancer

ESMO 2020 Virtual Data Watch - Skin Cancer (Melanoma and Non-Melanoma)

KRAS in the Landscape of Emerging Biomarkers in Lung Cancer

Featuring:
Dr. Adrian Sacher
Dr. Zhaolin Xu
Chair:
Dr. Barbara Melosky

Lung Cancer

Featuring:
Dr. Don Morris

Lung Cancer

Featuring:
Dr. Nicolas Marcoux

Breakfast Symposium: Treatment Advances in NSCLC: The Impact of Emerging EGFRm Data On Canadian Practice

Featuring:
Dr. Frances Shepherd

Lung Cancer

Featuring:
Dr. Rosalyn Juergens

Le Future Est “ICI”: A Respirologist’s Perspective on Immune Checkpoint Inhibitor (ICI) Pneumonitis

Featuring:
Dr Shane Shapera

ECOG-ACRIN EA5161, KEYNOTE-604 & CASPIAN

Extensive Stage SCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Jeffrey Rothenstein

CHECKMATE 227 3 YEAR, CHECKMATE 9LA, CCTG BR34

Immunotherapy Updates in NSCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Jeffrey Rothenstein

NEJ026, Concurrent Osimertinib/Getfitinib, JNJ-61186372, Osimertinib 160MG, Poziotinib in exon 20

Metastatic NSCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Jeffrey Rothenstein

T-Dxd DESTINY-LUNG01, GEOMETRY, Sym015, METex14 SA and potential AR mechanisms

Stage IV NSCLC, Target HER2

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Jeffrey Rothenstein

CTONG 1104 & ADAURA

Adjuvant NSCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Jeffrey Rothenstein

Standard-dose vs. high-dose twice-daily thoracic TRT in LD SCLC

Featuring:
Dr. Bjorn Henning Gronberg

JCOG1205/1206 Trial

Featuring:
Dr. Hirotsugu Kenmotsu

ASCO20 Virtual Data Watch - Lung Cancer

Lung Cancer

Featuring:
Dr. Randeep Sangha

Lung Cancer Update

Featuring:
Dr. Susanna Cheng

Lunch Symposium: BioSimilars

Featuring:
Dr. Christine Brezden-Masley / Mr. Sean Hopkins

Clinical Evidence For Immune-therapies In Practice - Melanoma

Featuring:
Dr. Scott Ernst

Clinical Evidence For Immune-therapies In Practice - Lung Cancers

Featuring:
Dr. Rosalyn Juergens

Small Cell Lung Cancer, Current and Emerging Options

Featuring:
Dr. Stephanie Brule

How to Interpret a Complicated Clinical Trial

Featuring:
Dr. Andrew Robinson

ALK Driver Mutations

Featuring:
Dr. Rosalyn Juergens

Panel Discussion

Featuring:
Dr. Wael Hanna, Dr. Anthony Brade, Dr. Parneet Cheema

Locally Advanced - Medical Perspective

Featuring:
Dr. Parneet Cheema

Locally Advanced - Radiation Perspective

Featuring:
Dr. Anthony Brade

Locally Advanced - Surgeon Perspective

Featuring:
Dr. Wael Hanna

Recent Advances in Transbronchial Diagnostics and Therapeutics of Lung Cancer

Featuring:
Dr. Kazuhiro Yasufuku

Screening Advocacy

Featuring:
Dr. Paul Wheatley-Price

Rare Mutations

Featuring:
Dr. Barbara Melosky

EGFR Combination Strategies

Featuring:
Dr. Paul Wheatley-Price

LBA5 FLAURA OS

Featuring:
Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Peter Ellis

IMpower110 Study

Featuring:
Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Peter Ellis

LBA4 Checkmate 227

Featuring:
Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Peter Ellis

1736O - IMpower133

Featuring:
Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Peter Ellis

CALGB 30610 (Alliance) Trial

Featuring:
Dr. Jeffrey Bogart

Real World Data in Lung Cancer - Implementing Immunotherapy into Practice

Lung Cancer

Featuring:
Dr. Doreen Ezeife

Case Studies (featuring Dr. Benoit Samson)

Featuring:
Dr. Corey Langer

Conclusions and Q&A Session

Featuring:
Dr. Corey Langer

Tumour Mutation Burden

Featuring:
Dr. Corey Langer

Angiogenesis Inhibition - ALK & EGFR + Patients

Featuring:
Dr. Corey Langer

Advanced Squamous Cell NSCLC

Featuring:
Dr. Corey Langer

Non-Squamous Advanced NSCLC: IMpower Trials

Featuring:
Dr. Corey Langer

Non-Squamous Advanced NSCLC: KEYNOTE Trials

Featuring:
Dr. Corey Langer

Introduction and Overview of Therapeutic Landscape

Featuring:
Dr. Corey Langer

Lung Cancer

Featuring:
Dr. Adrian Sacher

Lung Cancer

Featuring:
Dr. Sara Soldera

Relay Trial

Featuring:
Dr. Barb Melosky
Dr. Parneet Cheema
Dr. Sanjay Popat

GEFITNIB Phase III Trial

Featuring:
Dr. Barb Melosky
Dr. Parneet Cheema
Dr. Sanjay Popat

TAK-788

Featuring:
Dr. Barb Melosky
Dr. Parneet Cheema
Dr. Sanjay Popat

Geometry and TEPOTINIB Study

Featuring:
Dr. Barb Melosky
Dr. Parneet Cheema
Dr. Sanjay Popat

Adjuvant Therapy

Featuring:
Dr. Barb Melosky
Dr. Parneet Cheema
Dr. Sanjay Popat

Non-Squamous Advanced NSCLC: KEYNOTE Trials

Featuring:
Dr. Corey Langer

Non-Squamous Advanced NSCLC: IMpower Trials

Featuring:
Dr. Corey Langer

Introduction and Case Presentation - Dr. Jeff Rothenstein

Featuring:
Dr. Corey Langer

Advanced Squamous Cell NSCLC

Featuring:
Dr. Corey Langer

Angiogenesis Inhibition - ALK & EGFR + Patients

Featuring:
Dr. Corey Langer

Tumour Mutation Burden

Featuring:
Dr. Corey Langer

Conclusions and Q&A Session

Featuring:
Dr. Corey Langer

NRG-LU001 Study

Featuring:
Dr. Theo Tsakiridis

Trilaciclib on myelosupression in SC Lung Cancer

Featuring:
Dr. Lowell Hart

Lung Cancer

Featuring:
Dr. Krista Noonan

Best of Oncology East 2018 - Lung Cancer

Featuring:
Dr. Jeff Rothenstein

Clinical Evidence for Immuno-Therapies in Practice in Lung Cancers

Featuring:
Dr. Rosalyn Juergens

Satellite Symposium - Sequencing of ALK Inhibitors in NSCLC

Featuring:
Dr. Parneet Cheema

First-line Immunotherapy

Featuring:
Dr. Rosalyn Juergens

Immunotherapy Panel Discussion

Featuring:
Dr. Paul Wheatley-Price
Dr. Rosalyn Juergens
 

Debate: Trimodality vs Chemotherapy + Radiation +Durvalumab in Borderline Resectable Stage III NSCLC

Featuring:
Dr. Peter Ellis
Dr. Wael Hanna

Panel Discussion 

Featuring:
Dr. Paul Wheatley-Price
Dr. Rosalyn Juergens
Dr. Peter Ellis
Dr. Wael Hanna

Panel Discussion 

Featuring:
Dr. Penelope Bradbury
Dr. Arjun Saghal
Dr. Patrick Cheung
Dr. Anna Bendzsak

Management of Brain Metastases

Featuring:
Dr. Arjun Saghal

Oligoprogression/Oligometastases and Consolidative Radiation

Featuring:
Dr. Patrick Cheung

Advanced Technique EUS/EBUS

Featuring:
Dr. Anna Bendzsak

Beyond EGFR and ALK

Featuring:
Dr. Glenwood Goss

Updates in Molecular Testing, Biomarkers, and NGS Reports

Featuring:
Dr. Ming Tsao 

EGFR Positive NSCLC

Featuring:
Dr. Adrian Sacher

Panel Discussion 

Featuring:
Dr. Parneet Cheema
Dr. Barbara Melosky
Dr. Ming Tsao
Dr. Adrian Sacher

Prophylactic Cranial Irradiation (PCI) in Small-Cell Lung Cancer

Featuring:
Dr. Anthony Brade

Systemic Update and Panel Discussion

Featuring:
Dr. Frances Shepherd:
Dr. Anthony Brade:
Dr. Peter Ellis

Satellite Symposium - New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Winson Cheung

Best of Lung Cancer Summit 2018

November 2nd, 2018
Toronto, ON

IMPOWER 130 and 132 Trials - Updates from Immunotherapy in NSCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema

B-F1RST TRIAL - Updates in Blood-based Biomarkers in NSCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema

IFCT-1603 Trial

Featuring:
Dr. Jean-Louis Pujol

B-F1RST Trial

Featuring:
Dr. Edward Kim

Updates from the PACIFIC Trial

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema

FLAURA Trial - Updates in EGFR Associated NSCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema

IASLC 19th World Conference on Lung Cancer: Q&A ON ALK INHIBITORS

Featuring:
Dr. Ross Camidge
Dr. Barbara Melosky

IASLC 19th World Conference on Lung Cancer: Roundtable Discussion

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Tony Mok

IMpower 133 Trial

Featuring:
Dr. Stephen Liu

Refusing Surgery in Early Stage Lung Cancer

Featuring:
Dr. Brendan Stiles

DS-8201a in HER2 NSCLC

Featuring:
Dr. Junjli Tsurutani

Sublobar Resection in Screen-Detected Lung Cancer

Featuring:
Dr. Brendan Stiles

ALTA-1L Trial

Featuring:
Dr. Ross Camidge

LUME-Meso Trial

Featuring:
Dr. Girgio Scagliotti

5 Year PFS & OS in Synchronous Oligometastases

Featuring:
Dr. Dirk De Ruysscher

Ropotrectinib in ROS1 Fusion-Positive NSCLC

Featuring:
Dr. Jessica Lin

MISSILE-NSCLC Trial

Featuring:
Dr. David Palma

Phase 1/2 Results from ECHO 202/KEYNOTE 037

Featuring:
Dr. Liza Villaruz

ALIVE: Advanced Lung Cancer Intervention for EGFR-Positive Mutation Patients

Featuring:
Dr. Barbara Melosky

ALIVE: Advanced Lung Cancer Intervention for EGFR-Positive Mutation Patients

Featuring:
Dr. Barbara Melosky
August 31st, 2018

Best of ASCO Vancouver 2018 - Lung Cancer

Featuring:
Dr. Cheryl Ho

Best of ASCO Toronto 2018 - Lung Cancer

Featuring:
Dr. Adrian Sacher

Best of ASCO Montreal 2018 - Lung Cancer

Featuring:
Dr. Natasha Leighl

Locally Advanced Non-Small Lung Cancer Practice Update

Featuring:
Dr. Parneet Cheema

CCGA Study

Featuring:
Dr. Geoffrey Oxnard

LN Collection Kit for NSCLC Resections

Featuring:
Dr. Raymond Osarogiabon

NEJ009 Trial

Featuring:
Dr. Akira Inoue

Lung Cancer Screening Rates: Data from the Lung Cancer Screening Registry

Featuring:
Dr. Danh Pham

DREAM Study

Featuring:
Dr. Anna Nowak

ARCHER 1050 Trial

Featuring:
Dr. Tony Mok

NEJ009 Trial

Featuring:
Dr. Akira Inoue

Immunotherapy Updates in NSCLC

Dr. Barbara Melosky
Dr. Rosalyn Juergens
Dr. Parneet Cheema

EGFR-Associated NSCLC Updates

Dr. Barbara Melosky
Dr. Rosalyn Juergens
Dr. Parneet Cheema

Web-mediated Follow up vs. Routine Surveillance in Lung Cancer

Featuring:
Dr. Fabrice Denis

Updates in Stage 3 Lung Cancer, Small Cell Lung Cancer, Mesothelioma & Rare-Driver Mutations

Dr. Barbara Melosky
Dr. Rosalyn Juergens
Dr. Parneet Cheema

What has Liquid Biopsy taught us?

Featuring:
Dr. Suresh Ramalingam

Introduction & Recent Updates in EGFR-Mutated NSCLC

Featuring:
Dr. Suresh Ramalingam

Mechanisms of Resistance

Featuring:
Dr. Suresh Ramalingam

Combination Therapy

Featuring:
Dr. Suresh Ramalingam

Case Discussion & Question Period

Featuring:
Dr. Suresh Ramalingam

Case Presentation and Question Period

Featuring:
Dr. Tony Mok

Introduction & Biomarker Selection

Featuring:
Dr. Tony Mok

Optimal First Line Therapy

Featuring:
Dr. Tony Mok

Management of Resistance

Featuring:
Dr. Tony Mok

Best of Oncology East 2017 - Lung Cancer

Featuring:
Dr. Jeff Rothenstein

Best of Oncology West 2018 - Lung Cancer

Featuring:
Dr. Shantanu Banerji

Highlights from the 18th World Conference on Lung Cancer

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema

Lunch Presentation: Biomarker Testing in Lung Cancer - Detection

Featuring:
Dr. Brandon Sheffield

Lunch Presentation: Biomarker Testing in Lung Cancer - Use in Patient Treatment

Featuring:
Dr. Glenwood Goss

Debate: Should an EGFR TKI Be the Standard of Care in the Adjuvant Treatment of EGFR Mutated NSCLC? -Yes

Featuring:
Dr. Natasha Leighl

Debate: Should an EGFR TKI Be the Standard of Care in the Adjuvant Treatment of EGFR Mutated NSCLC? -No

Featuring:
Dr. Peter Ellis

Debate: Should an EGFR TKI Be the Standard of Care in the Adjuvant Treatment of EGFR Mutated NSCLC? -Q&A

Featuring:
Dr. Natasha Leighl
Dr. Peter Ellis

Breakfast Presentation: Immuno-Oncology in Lung Cancer - Where Are We Today?

Featuring:
Dr. Paul Wheatley-Price

Breakfast Presentation: Immuno-Oncology in Lung Cancer - Future Challenges

Featuring:
Dr. Ross Camidge

Breakfast Presentation: Immuno-Oncology in Lung Cancer - Q&A

Featuring:
Dr. Ross Camidge
Dr. Paul Wheatley-Price
Dr. Peter Ellis

Update on the Management of EGFR Mutated NSCLC

Featuring:
Dr. Frances Shepherd

Treatment Options in ALK+ NSCLC Patients

Featuring:
Dr. Jeff Rothenstein

Treatment Options With Alectinib as a First Line Therapy

Featuring:
Dr. Parneet Cheema

Management of NSCLC Brain Metastases in the Targeted Therapy Era

Featuring:
Dr. Anthony Brade

Management of NSCLC Brain Metastases in the Targeted Therapy Era

Featuring:
Dr. Paul Wheatley-Price

Management of Stage 3 Disease - Where are we in 2017? Medical Oncology Perspective

Featuring:
Dr. Andrew Robinson

Management of Stage 3 Disease - Where are we in 2017? Radiation Oncology Perspective

Featuring:
Dr. Andrea Bezjak

Management of Stage 3 Disease - Where are we in 2017? Surgical Oncology Perspective

Featuring:
Dr. Wael Hanna

Immunotherapy in Lung Cancers

Featuring:
Dr. Rosalyn Juergens

Key Trials in Lung Cancer - PACIFIC & FLAURA Studies

Featuring:
Dr. Natasha Leighl
Dr. Ron Burkes
Dr. Barb Melosky

Advances in Lung Cancer Immunotherapy

Featuring:
Dr. Natasha Leighl
Dr. Ron Burkes
Dr. Barb Melosky

IFCT-0302 Trial Discussion

Featuring:
Dr. Natasha Leighl
Dr. Ron Burkes
Dr. Barb Melosky

Blood-Based Biomarkers for Immune Therapy

Featuring:
Dr. Natasha Leighl
Dr. Ron Burkes
Dr. Barb Melosky

Phase III ALUR Study

Featuring:
Dr. Silvia Novello, MD, PhD

ABOUND.2L+ Study

Featuring:
Dr. Daniel Morgensztern, MD

KEYNOTE-021 Trial

Featuring:
Dr. Corey Langer, MD

VEGFR-Sparing Potent RET Inhibitor in NSCLC

Featuring:
Dr. Lyudmila Bazhenova, MD

Updated Results from

Featuring:
Dr. Tony Mok

IASLC World Conference on Lung Cancer 2017

October 15-18, 2017
Yokohama, Japan

Updates in ALK-Rearranged NSCLC

Featuring:
Dr. Parneet Cheema
Dr. Charles Butts
Dr. Don Morris

Small-Cell Lung Cancer Updates

Featuring:
Dr. Parneet Cheema
Dr. Charles Butts
Dr. Don Morris

Updates in the Adjuvant Setting for NSCLC

Featuring:
Dr. Parneet Cheema
Dr. Charles Butts
Dr. Don Morris

Metastatic NSCLC Updates

Featuring:
Dr. Parneet Cheema
Dr. Charles Butts
Dr. Don Morris

Maintenance Pembrolizumab in ES-SCLC patients

Featuring:
Dr. Shirish Gadgeel

IFCT-GFPC-1101 Trial

Featuring:
Dr. Maurice Perol

CTONG 1104 Trial

Featuring:
Dr. Yi-Long Wu

AvaALL Trial

Featuring:
Dr. Jaafar Bennouna

ARCHER 1050 Trial

Featuring:
Dr. Tony Mok

Best of ASCO Toronto 2017 - Lung Cancer

Featuring:
Dr. Jeff Rothenstein

Lunch Presentation - Targeted Therapies in Advanced Lung Cancer - The Next generation

Featuring:
Dr. Parneet Cheema

Lunch Presentation - Targeted Therapies in Advanced Lung Cancer - The Next generation

Featuring:
Dr. Jeff Rothenstein

Best of ASCO Vancouver 2017 - Lung Cancer

Featuring:
Dr. Barb Melosky

The Molecular Revolutions in Lung Cancer

Featuring:
Dr. Tony Mok
April 5th, 2017

Panel Discussion: What I-O Really Means for Your NSCLC Patients

Featuring:
Dr. Sunil Verma
Dr. Solange Peters
Ms. Christina Sit

Module 1: Detection

Featuring:
Dr. Tony Mok

Module 2: Treatment

Featuring:
Dr. Tony Mok

Module 3: Genomic Profiling

Featuring:
Dr. Tony Mok

Module 4: Question & Answer Session

Featuring:
Dr. Tony Mok

CLCCO 2017

February 9-10, 2017
Vancouver, BC

IASLC World Conference on Lung Cancer 2016 Roundtable

Featuring:
Dr. Barbara Melosky
Dr. Rosalyn Juergens
Dr. Paul Wheatley-Price

IASLC World Conference on Lung Cancer 2016 IND226 Trial

Featuring:
Dr. Rosalyn Juergens

IASLC World Conference on Lung Cancer 2016 ASCEND-4 Trial

Featuring:
Dr. Gilberto de Castro Junior

Best of Oncology East 2016 - Lung Cancer

Featuring:
Dr. Jeff Rothenstein

Lunch Symposium: ALK+ NSCLC: State of the Art

Featuring:
Dr. Parneet Cheema
Dr. Jeff Rothenstein

Panel Discussion: Hot Topics in Radiation and Surgery

Featuring:
Dr. Ron Burkes
Dr. Wael Hanna
Dr. Anthony Brade

Breakfast Symposium: Evolution of EGFRs and Immunotherapies in Treating NSCLC

Featuring:
Dr. Adrian Sacher

Lessons Learned - The Weird & the Wonderful

Featuring:
Dr. David Hogg

Immunotherapy in Lung Cancer - Things You Need to Know

Featuring:
Dr. Parneet Cheema

Pathways to Immunotherapy & New Drug Advances

Featuring:
Dr. Rosalyn Juergens

Lunch Symposium: ALK-Rearranged Non-Small Cell Lung Cancer - Optimizing the Continuum of Care

Featuring:
Dr. Daniel Costa

Updates in Surgery for Lung Cancer

Featuring:
Dr. Wael Hanna

Updates in Radiation for Lung Cancer

Featuring:
Dr. Anthony Brade

Molecular Profiling: Are We Ready For Liquid Biopsies

Featuring:
Dr. Ming Tsao

Update on ALK: So Much For So Few

Featuring:
Dr. Jeff Rothenstein

EGFR: What's New for 2016 & Beyond

Featuring:
Dr. Adrian Sacher

Best of Lung Cancer Summit 2016

October 21, 2016
Toronto, ON

Round Table Discussion: Highlights in Lung Cancer from ESMO 2016

Featuring:
Dr. Mark Vincent
Dr. Ron Burkes

IMPRESS Study

Featuring:
Dr. Gilberto Lopes

LUX-LUNG 7 Trial

Featuring:
Dr. Gilberto Lopes

Keynote 24 Study

Featuring:
Dr. Gilberto Lopes

ASCEND-5 Study

Featuring:
Dr. Giorgio Scagliotti

Final results of CSLC0501

Featuring:
Dr. Yi-Long Wu

Ceritinib in ALKi-naïve patients with ALK+ NSCLC

Featuring:
Dr. Enriqueta Felip

Best of ASCO Vancouver 2016 - Lung Cancer

Featuring:
Dr. Gwyn Bebb

E1505 Study

Featuring:
Dr. Heather Wakelee

Best of ASCO Toronto 2016 - Lung Cancer

Featuring:
Dr. Penelope Bradbury

EGFR Target Therapy: State of the Art

Featuring:
Dr. Barb Melosky

Case Discussion: Targeting EGFR in the Real World

Featuring:
Dr. Jeff Rothenstein

Best of ASCO Montreal 2016 - Lung Cancer

Featuring:
Dr. Victor Cohen

Crizotinib in MET Exon 14-Altered NSCLC

Featuring:
Dr. Alexander Drilon

Intensity-Modulated Radiation vs Passively Scattered Proton Therapy for NSCLC

Featuring:
Dr. Zhongxing Liao

CheckMate 032 Trial

Featuring:
Dr. Ronald Burkes

Luret Study

Featuring:
Dr. Takashi Seto

Best of Oncology West 2017 - Lung Cancer

Featuring:
Dr. Janessa Laskin

Dr. Simon Raphael Lung Speaker Tour Video 2015

Lung Speaker Tour 2015

Video 2: Treatment Overview

Featuring:
Dr. Parneet Cheema

Video 3: Therapeutic Update

Featuring:
Dr. Parneet Cheema

Video 4: Future Directions & Practice Update Summary

Featuring:
Dr. Parneet Cheema

Immune Checkpoint Inhibition in NSCLC

Featuring:
Dr. Naiyer Rizvi

Commentary on the LUX-Lung 8 Trial

Featuring:
Dr. Glendwood Goss

Popular Videos

Real World Data in Lung Cancer - Implementing Immunotherapy into Practice

Best of Lung Cancer Summit 2018

November 2nd, 2018
Toronto, ON

ALIVE: Advanced Lung Cancer Intervention for EGFR-Positive Mutation Patients

Featuring:
Dr. Barbara Melosky
August 31st, 2018

The Molecular Revolutions in Lung Cancer

Featuring:
Dr. Tony Mok
April 5th, 2017

Best of Lung Cancer Summit 2016

October 21, 2016
Toronto, ON

Locally Advanced Non-Small Lung Cancer Practice Update

Featuring:
Dr. Parneet Cheema

IASLC World Conference on Lung Cancer 2017

October 15-18, 2017
Yokohama, Japan

Highlights from the 18th World Conference on Lung Cancer

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema

Lung Cancer

Featuring:
Dr. Krista Noonan

ASCO20 Virtual Data Watch - Lung Cancer

KRAS in the Landscape of Emerging Biomarkers in Lung Cancer

Featuring:
Dr. Adrian Sacher
Dr. Zhaolin Xu
Chair:
Dr. Barbara Melosky

ESMO 2020 Virtual Data Watch - Lung Cancer

ADAURA Trial: CNS disease recurrence

Featuring:
Dr. Masahiro Tsuboi

Le Future Est “ICI”: A Respirologist’s Perspective on Immune Checkpoint Inhibitor (ICI) Pneumonitis

Featuring:
Dr Shane Shapera

CTONG 1104 & ADAURA

Adjuvant NSCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Jeffrey Rothenstein

Introduction and Overview of Therapeutic Landscape

Featuring:
Dr. Corey Langer

CHECKMATE 227 3 YEAR, CHECKMATE 9LA, CCTG BR34

Immunotherapy Updates in NSCLC

Featuring:
Dr. Barbara Melosky
Dr. Parneet Cheema
Dr. Jeffrey Rothenstein

Change on the Horizon: Updates in Small Cell Lung Cancer

Featuring:
Dr. Peter Ellis
Chair:
Dr. Stephanie Snow

REACTION Study

Featuring:
Dr. Benjamin Besse

Lung Cancer

Featuring:
Dr. Rosalyn Juergens

Defining the scope of eligibility for concurrent chemoradiation therapy for NSCLC

Featuring:
Dr. Parneet Cheema
Dr. Anthony Brade

Best of Oncology East 2018 - Lung Cancer

Featuring:
Dr. Jeff Rothenstein

Lung Cancer Update

Featuring:
Dr. Susanna Cheng

Clinical Evidence for Immuno-Therapies in Practice in Lung Cancers

Featuring:
Dr. Rosalyn Juergens

Lung Cancer

Featuring:
Dr. Randeep Sangha

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

DISCLAIMER: The educational materials and other information which are accessible on this website (the “Information”) have been expertly curated for, and are intended exclusively for the consumption and use by, Health Care Practitioners (“Qualified Practitioner(s)”) or professionals working in the Oncology industry . The Information is not intended for consumption, access or use by the general public, including patients, unless such a user is a Qualified Practitioner. You acknowledge and agree that your use of this website will at all times be in full compliance with the website Terms of Use.

  • Breast Cancer
  • Lung Cancer
  • GI Cancer
  • GU Cancer
  • Head and Neck
  • Hematology
  • Melanoma
  • Gynecology
  • Global Cancer Control
  • Other Topics
  • Upcoming Events
  • Trainee Resources
  • E-Learning Portal
  • Best of Oncology Weekly
  • About Us
  • Faculty
  • Contact Us
  • Site Policies
  • Job Postings
  • Cancer and Aging
© Copyright 2021 Oncology Education, site by: BigBlock Studios